SightfileU.S. market data from official filings

Companies › ASRT

Assertio Holdings Inc (ASRT)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001808665 · EDGAR filings · Updated 2026-07-07

Assertio Holdings Inc (ASRT) has reported institutional ownership of 38.3%, with 66 institutional managers holding positions valued at $47.6M per the latest 13F reporting period. SEC filings include an active material impairment disclosure (8-K Item 2.06), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings, triggering event that accelerates or increases a direct financial obligation (8-K Item 2.04).

Institutional ownership
38.3%
Institutional managers
66
Reported 13F value
$47.6M
Insider activity
32 trans.
−$6.81K net selling
Data flags
4 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Assertio Holdings Inc has 66 institutional holders and institutional ownership of 38.3%.

Insider activity

Insiders reported 32 transactions (0 buys, 1 sells) across 9 reporting insiders, with a net reported value of −$6.81K.

Data flags from SEC filings

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2026-06-16 (recurring since 2020-12-29) — source filing. The authoritative details are those stated in the filing itself.
Active triggering event that accelerates or increases a direct financial obligation (8-K Item 2.04), most recently filed 2026-06-16 (recurring since 2026-06-16) — source filing. The authoritative details are those stated in the filing itself.
Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-03-16 (recurring since 2020-08-10) — source filing. The authoritative details are those stated in the filing itself.
Active material impairment disclosure (8-K Item 2.06), most recently filed 2021-02-04 (recurring since 2021-02-04) — source filing. The authoritative details are those stated in the filing itself.

Related companies

SPRUCE BIOSCIENCES INC COM NEW (SPRB) · Spero Therapeutics Inc (SPRO) · CARLSMED INC (CARL) · MAXCYTE INC (MXCT) · PMV PHARMACEUTICALS INC (PMVP) · Oramed Pharmaceuticals Inc (ORMP)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-07.